Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: Adrenal incidentalomas are mostly nonfunctioning adrenocortical adenomas (NFI). However, in 5%–12% of the patients a preclinical Cushing's syndrome (PCS) with autonomous cortisol production by the tumour is present. Since urinary free cortisol excretion is not sensitive enough to determine subclinical hypercortisolism, in the present study more sensitive indicators of daily cortisol production were measured. Design: (1) Tetrahydrocortisol, tetrahydrocortisone, urinary free cortisone together with urinary free cortisol were measured in 35 patients with adrenal incidentalomas (29 NFI and six PCS) and in 35 healthy controls. (2) Since little is known about daily aldosterone production, aldosterone metabolite excretions were measured. (3) As recently reported, ACTH stimulation revealed an increased response of precursors of the glucocorticoid and mineralocorticoid pathway. To find out which steroidogenic enzymes have altered activities, a 1–24ACTH stimulation test (250 μg i.v.) was carried out in 25 patients and 18 healthy controls with determination of multiple steroids. (4) Finally, since it was assumed that 21‐hydroxylase deficiency or even 11b‐hydroxylase deficiency may be involved in adrenal tumourigenesis, the prevalence of germline CYP21B and CYP11B1 mutations were studied in the same patients, who had underwent the ACTH stimulation test. Results: (1) Glucocorticoid metabolites were within the normal range in all but three patients with NFI. As a group, the patients had subtle alterations in cortisol metabolism. Tetrahydrocortisol excretion was elevated in NFI and PCS compared with normal subjects (2á1 ± 0á2 and 2á5 ± 0á5 vs. 1á5 ± 0á1 mg 24 h−1; P < 0á05). Accordingly, the twofold elevation of the tetrahydrocortisol/free cortisol ratio indicates an increased 5β‐reduction of cortisol in the liver. (2) Tetrahydroaldosterone and aldosterone‐18‐glucuronide excretions were not different to controls. (3) In patients with incidentalomas an increased response to ACTH was seen for 17‐hydroxyprogesterone (595 ± 133 vs. 160 ± 25 ng dL−1), 21‐desoxycortisol (105 ± 25 vs. 29 ± 9 ng dL−1) and 11‐desoxycortisol (401 ± 40 vs. 293 ± 17 ng dL−1). (4) In only one of 25 patients, a heterozygous deletion in exon 3 of the CYP21B gene was detected. Conclusions: (1) In conclusion, even the excretion of the main glucocorticoid metabolites is not a marker sensitive enough to distinguish between NFI and PCS. However, it is also possible that alterations in cortisol secretion are qualitative rather than quantitative. (2) Zona glomerulosa function is not influenced. (3) The elevation of 21‐desoxycortisol argues against an impairment of 11β‐hydroxylase and favours a decreased activity of 21‐hydroxylase. All others had wild‐type sequences of both genes. (4) In conclusion, neither 21‐hydroxylase deficiency nor 11β‐hydroxylase deficiency are predisposing factors for adrenal tumourigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of human steroid 21-hydroxylase genes.
White, P. C., New, M. I., & Dupont, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5111 · Cited by 569
White, P. C., Dupont, J., New, M. I., Leiberman, E., Hochberg, Z., & Rösler, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115182 · Cited by 267
Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.
Jaresch, S., Kornely, E., Kley, H. K., & Schlaghecke, R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1311000 · Cited by 227
Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
Osella, G., Terzolo, M., Borretta, G., Magro, G., Alí, A., Piovesan, A., Paccotti, P., & Angeli, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989452 · Cited by 206
Abnormalities of endocrine function in patients with clinically silent adrenal masses.
Ambrosi, B., Peverelli, S., Passini, E., Re, T., Ferrario, R., Colombo, P., Sartorio, A., & Faglia, G. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320422 · Cited by 136
Flecchla, D., Mazza, E., Carllni, M., Blatto, A., Ollvlerl, F., Serra:, G., Camannl, F., & Messlna, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01852.x · Cited by 75
Evaluation of hormonal function in a series of incidentally discovered adrenal masses.
Bondanelli, M., Campo, M., Trasforini, G., Ambrosio, M. R., Zatelli, M. C., Franceschetti, P., Valentini, A., Pansini, R., & Uberti, E. C. D. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90176-1 · Cited by 61
Increased 17 a‐hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause or effect?
Del Monte, P., Bernasconi, D., Bertoiazzi, L., Meozzi, M., Badaracco, B., Torre, R., & Marugo, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01875.x · Cited by 38
Cited by
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases
Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168
Falhammar, H., & Torpy, D. J. (2016) · Endocrine Practice · doi:10.4158/ep151085.ra · Cited by 63
The urinary steroid profile in patients diagnosed with adrenal incidentaloma
Kotłowska, A., Maliński, E., Sworczak, K., Kumirska, J., & Stepnowski, P. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.12.027 · Cited by 36
“To add, it has been suggested that the elevation of terahydrocortisol production may be connected to the increased 5β-reductase activity in the liver [29,30].”
Background
Metadata
- Authors
- Maser‐Gluth, C., Reincke, M., Allolio, B., & Schulze, E.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2000-12
- Volume
- 30
- Issue
- s3
- Pages
- 83-86
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2052777604
- Cited by
- 32
- References
- 8
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas. https://app.cochat.ai/papers/10.1046/j.1365-2362.2000.0300s3083.x
- The paper
- Maser‐Gluth, C., Reincke, M., Allolio, B., & Schulze, E. (2000). Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas. European Journal of Clinical Investigation. https://doi.org/10.1046/j.1365-2362.2000.0300s3083.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.